|
2021
|
Invention
|
Solid dispersions containing amorphous nintedanib, their synthesis and use thereof. The invention... |
|
2020
|
Invention
|
Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol co... |
|
|
Invention
|
Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and admi... |
|
|
Invention
|
Inclusion complexes of pharmaceuticals and cyclic oligomers. Pharmaceutical formulations includin... |
|
|
Invention
|
Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administrati... |
|
2018
|
Invention
|
Improved drug formulations. The disclosure provides for improved pharmaceutical compositions cont... |
|
2016
|
Invention
|
Improved formulations of deferasirox and methods of making the same. The disclosure provides for ... |
|
2015
|
Invention
|
Improved formulations of vemurafenib and methods of making the same.
The disclosure provides for... |
|
|
Invention
|
Improved formulations of vemurafenib and methods of making the same. The disclosure provides for ... |
|
2014
|
Invention
|
Multiple speed process for preserving heat sensitive portions of a thermokinetically melt blended... |
|
2012
|
Invention
|
Pharmaceutical formulations of acetyl-11-keto-b-boswellic acid, diindolylmethane, and curcumin fo... |
|
|
Invention
|
Pharmaceutical formulations of acetyl-11-keto-β-boswellic acid, diindolylmethane, and curcumin fo... |
